

U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.
You can purchase shares of YD Bio (NASDAQ:YDES) through any online brokerage.
Other companies in YD Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for YD Bio to provide a consensus price target.
The stock price for YD Bio (NASDAQ: YDES) is $5.7 last updated October 27, 2026 at 7:18 AM EDT.
There are no upcoming dividends for YD Bio.
YD Bio does not have any upcoming earnings scheduled.
There is no upcoming split for YD Bio.
YD Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT...